Cargando…
Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes
AIMS: Type 2 diabetes is characterised by increased plasma concentrations of pro-inflammatory cytokines [such as tumour necrosis factor – alpha; TNF-α] and soluble forms of adhesion molecules involved in leukocyte – endothelial interactions. These molecules are synthesised as transmembrane proteins...
Autores principales: | Worley, Joanna R, Hughes, David A, Dozio, Nicoletta, Gavrilovic, Jelena, Sampson, Mike J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2041943/ https://www.ncbi.nlm.nih.gov/pubmed/17714581 http://dx.doi.org/10.1186/1475-2840-6-21 |
Ejemplares similares
-
Monocyte matrix metalloproteinase production in Type 2 diabetes and controls – a cross sectional study
por: Baugh, Mark D, et al.
Publicado: (2003) -
Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetes
por: Sampson, Mike, et al.
Publicado: (2004) -
The ADAM metalloproteinases
por: Edwards, Dylan R., et al.
Publicado: (2008) -
Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis
por: Kumar, Nathella P., et al.
Publicado: (2020) -
Evaluation of monocyte to high-density lipoprotein ratio, lymphocytes, monocytes, and platelets in psoriasis()()
por: Aktaş Karabay, Ezgi, et al.
Publicado: (2020)